{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T04:40:17Z","timestamp":1776055217096,"version":"3.50.1"},"reference-count":93,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.ad.2018.11.009","type":"journal-article","created":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T17:18:16Z","timestamp":1557854296000},"page":"434-447","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Melanoma cut\u00e1neo en el anciano: revisi\u00f3n de un problema creciente"],"prefix":"10.1016","volume":"110","author":[{"given":"N.","family":"Iglesias-Pena","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Paradela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Tejera-Vaquerizo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Boada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2018.11.009_bib0470","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.piel.2017.07.017","article-title":"Disecci\u00f3n ganglionar en el paciente de edad avanzada con melanoma","volume":"33","author":"Moreno-Ram\u00edrez","year":"2018","journal-title":"Piel."},{"key":"10.1016\/j.ad.2018.11.009_bib0475","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1245\/s10434-011-2015-6","article-title":"Melanoma in the older patient: Measuring frailty as an index of survival","volume":"18","author":"Lange","year":"2011","journal-title":"Ann Surg Oncol."},{"key":"10.1016\/j.ad.2018.11.009_bib0480","doi-asserted-by":"crossref","unstructured":"Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Kosary CL, et al. (Eds). SEER Cancer Statistics Review, 1975-2014, National Cancer Institute. Bethesda, MD, https:\/\/seer.cancer.gov\/csr\/1975_2014\/, based on November 2016 SEER data submission, posted to the SEER web site, April 2017. DOI: 10.1016\/j.carbpol.2013.11.026","DOI":"10.1016\/j.carbpol.2013.11.026"},{"key":"10.1016\/j.ad.2018.11.009_bib0485","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1038\/jid.2008.423","article-title":"Increasing burden of melanoma in the United States","volume":"129","author":"Linos","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ad.2018.11.009_bib0490","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ad.2015.12.008","article-title":"Incidencia y mortalidad del c\u00e1ncer cut\u00e1neo en Espa\u00f1a: revisi\u00f3n sistem\u00e1tica y metaan\u00e1lisis","volume":"107","author":"Tejera-Vaquerizo","year":"2016","journal-title":"Actas Dermosifiliogr."},{"key":"10.1016\/j.ad.2018.11.009_bib0495","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nrclinonc.2010.1","article-title":"Epidemiology and treatment of melanoma in elderly patients","volume":"7","author":"Tsai","year":"2010","journal-title":"Nat Rev Clin Oncol."},{"key":"10.1016\/j.ad.2018.11.009_bib0500","doi-asserted-by":"crossref","first-page":"643","DOI":"10.14336\/AD.2017.0503","article-title":"Skin cancer epidemics in the elderly as an emerging issue in geriatric oncology","volume":"8","author":"Garcovich","year":"2017","journal-title":"Aging Dis."},{"key":"10.1016\/j.ad.2018.11.009_bib0505","unstructured":"Instituto de Salud Carlos III. Servicio interactivo de informaci\u00f3n epidemiol\u00f3gica (Ariadna) [consultado 26 Jun 2018]. Disponible en: http:\/\/ariadna.cne.isciii.es"},{"key":"10.1016\/j.ad.2018.11.009_bib0510","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.piel.2017.09.004","article-title":"Incidence and mortality of skin cancer in Spain","volume":"33","author":"Tejera-Vaquerizo","year":"2018","journal-title":"Piel."},{"key":"10.1016\/j.ad.2018.11.009_bib0515","doi-asserted-by":"crossref","unstructured":"Surveillance, Epidemiology, and End Results (SEER). Program Cancer Statistics Review, 1975\u20132015, National Cancer Institute [Internet]. Melanoma of the skin - Cancer Stat Fact [consultado 16 Sept 2018]. doi: 10.1083\/jcb.144.6.1219.","DOI":"10.1083\/jcb.144.6.1219"},{"key":"10.1016\/j.ad.2018.11.009_bib0520","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-016-1026-2","article-title":"Impact of aging on host immune response and survival in melanoma: An analysis of 3 patient cohorts","volume":"14","author":"Weiss","year":"2016","journal-title":"J Transl Med."},{"key":"10.1016\/j.ad.2018.11.009_bib0525","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1245\/s10434-013-3100-9","article-title":"Age as a prognostic factor in patients with localized melanoma and regional metastases","volume":"20","author":"Balch","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ad.2018.11.009_bib0530","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1002\/cncr.23359","article-title":"Age and gender are significant independent predictors of survival in primary cutaneous melanoma","volume":"112","author":"Lasithiotakis","year":"2008","journal-title":"Cancer."},{"key":"10.1016\/j.ad.2018.11.009_bib0535","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/CMR.0b013e328335a8dd","article-title":"Cutaneous melanoma in the elderly: Epidemiology, prognosis and treatment","volume":"20","author":"Lasithiotakis","year":"2010","journal-title":"Melanoma Res"},{"key":"10.1016\/j.ad.2018.11.009_bib0540","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0002-9610(98)00070-1","article-title":"Superior survival of young women with malignant melanoma","volume":"175","author":"Kemeny","year":"1998","journal-title":"Am J Surg."},{"key":"10.1016\/j.ad.2018.11.009_bib0545","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1200\/JCO.2001.19.16.3622","article-title":"Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system","volume":"19","author":"Balch","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ad.2018.11.009_bib0550","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1002\/cncr.11196","article-title":"Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma: An analysis of 3661 patients from a single center","volume":"97","author":"Azzola","year":"2003","journal-title":"Cancer."},{"key":"10.1016\/j.ad.2018.11.009_bib0555","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1200\/JCO.2004.03.074","article-title":"Prognostic factors of thin cutaneous melanoma: An analysis of the Central Malignant Melanoma Registry of the German Dermatological society","volume":"22","author":"Leiter","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ad.2018.11.009_bib0560","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1002\/cncr.20602","article-title":"Invasive cutaneous malignant melanoma in Sweden, 1990-1999: A prospective, population-based study of survival and prognostic factors","volume":"101","author":"Lindholm","year":"2004","journal-title":"Cancer."},{"key":"10.1016\/j.ad.2018.11.009_bib0565","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1245\/s10434-007-9433-5","article-title":"Impact of false-negative sentinel lymph node biopsy on survival in patients with cutaneous melanoma","volume":"14","author":"Carac\u00f2","year":"2007","journal-title":"Ann Surg Oncol."},{"key":"10.1016\/j.ad.2018.11.009_bib0570","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1111\/j.1532-5415.2006.00943.x","article-title":"Socioeconomic status and survival in older patients with melanoma","volume":"54","author":"Reyes-Ortiz","year":"2006","journal-title":"J Am Geriatr Soc."},{"key":"10.1016\/j.ad.2018.11.009_bib0575","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/sj.bjc.6603216","article-title":"Recent trends in cutaneous malignant melanoma in the Yorkshire region of England; incidence, mortality and survival in relation to stage of disease, 1993-2003","volume":"95","author":"Downing","year":"2006","journal-title":"Br J Cancer."},{"key":"10.1016\/j.ad.2018.11.009_bib0580","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/annonc\/mdm498","article-title":"Superior survival of females among 10 538 Dutch melanoma patients is independent of Breslow thickness, histologic type and tumor site","volume":"19","author":"De Vries","year":"2008","journal-title":"Ann Oncol."},{"key":"10.1016\/j.ad.2018.11.009_bib0585","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1245\/ASO.2004.04.015","article-title":"Correlation between prognostic factors and increasing age in melanoma","volume":"11","author":"Chao","year":"2004","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ad.2018.11.009_bib0590","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/cncr.22382","article-title":"The impact of factors beyond breslow depth on predicting sentinel lymph node positivity in melanoma","volume":"109","author":"Paek","year":"2007","journal-title":"Cancer."},{"key":"10.1016\/j.ad.2018.11.009_bib0595","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1002\/1097-0142(20010615)91:12<2401::AID-CNCR1274>3.0.CO;2-I","article-title":"The sentinel lymph node status is an important factor for predicting clinical outcome in patients with stage ii or ii cutaneous melanoma","volume":"91","author":"Muller","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.ad.2018.11.009_bib0600","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1245\/ASO.2004.03.044","article-title":"Mitotic rate and younger age are predictors of sentinel lymph node positivity: lessons learned from the generation of a probabilistic model","volume":"11","author":"Sondak","year":"2004","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ad.2018.11.009_bib0605","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ad.2014.10.012","article-title":"Factores predictivos del estado del ganglio centinela en el melanoma cut\u00e1neo: an\u00e1lisis mediante un \u00e1rbol de clasificaci\u00f3n y regresi\u00f3n","volume":"106","author":"Tejera-Vaquerizo","year":"2015","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.ad.2018.11.009_bib0610","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1245\/s10434-009-0420-x","article-title":"Age-related lymphatic dysfunction in melanoma patients","volume":"16","author":"Conway","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ad.2018.11.009_bib0615","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1245\/s10434-013-3464-x","article-title":"Age as a predictor of sentinel node met\u00e1stasis among patients with localized melanoma: An inverse correlation of melanoma mortality and incidence of sentinel node met\u00e1stasis among young and old patients","volume":"21","author":"Balch","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ad.2018.11.009_bib0620","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1001\/archderm.1997.03890460078009","article-title":"Aging and the skin immune system","volume":"10","author":"Sunderk\u00f6tter","year":"1997","journal-title":"Arch Dermatol."},{"key":"10.1016\/j.ad.2018.11.009_bib0625","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1749-6632.2009.05370.x","article-title":"Potential role of immunosenescence in cancer development","volume":"1197","author":"Fulop","year":"2010","journal-title":"Ann N Y Acad Sci."},{"key":"10.1016\/j.ad.2018.11.009_bib0630","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1586\/erp.11.14","article-title":"Metastatic melanoma in the older patient: Immunologic insights and treatment outcomes","volume":"11","author":"Hegde","year":"2011","journal-title":"Expert Rev Pharmacoeconomics Outcomes Res."},{"key":"10.1016\/j.ad.2018.11.009_bib0635","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/archderm.138.5.609","article-title":"Nodular type and older age as the most significant associations of thick melanoma in Victoria, Australia","volume":"138","author":"Chamberlain","year":"2002","journal-title":"Arch Dermatol."},{"key":"10.1016\/j.ad.2018.11.009_bib0640","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.jgo.2018.01.001","article-title":"Melanoma in the very elderly, management in patients 85 years of age and over","volume":"9","author":"Rees","year":"2018","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.ad.2018.11.009_bib0645","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1468-3083.2009.03367.x","article-title":"Growth rate as a prognostic factor in localized invasive cutaneous melanoma","volume":"24","author":"Tejera-Vaquerizo","year":"2010","journal-title":"J Eur Acad Dermatology Venereol."},{"key":"10.1016\/j.ad.2018.11.009_bib0650","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/CMR.0b013e328342f312","article-title":"Defining fast-growing melanomas: Reappraisal of epidemiological, clinical, and histological features","volume":"21","author":"Martorell-Calatayud","year":"2011","journal-title":"Melanoma Res"},{"key":"10.1016\/j.ad.2018.11.009_bib0655","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1001\/archderm.142.12.1551","article-title":"Rate of growth in melanomas: Characteristics and associations of rapidly growing melanomas","volume":"142","author":"Liu","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ad.2018.11.009_bib0660","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1001\/jama.292.22.2771","article-title":"Early diagnosis of cutaneous melanoma: Revisiting the ABCD criteria","volume":"292","author":"Abbasi","year":"2004","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.ad.2018.11.009_bib0665","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1001\/jamadermatol.2013.2466","article-title":"Dermoscopic evaluation of nodular melanoma","volume":"149","author":"Menzies","year":"2013","journal-title":"JAMA Dermatology."},{"key":"10.1016\/j.ad.2018.11.009_bib0670","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1111\/j.1365-2133.2004.05928.x","article-title":"Amelanotic\/hypomelanotic melanoma: Clinical and dermoscopic features","volume":"150","author":"Pizzichetta","year":"2004","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2018.11.009_bib0675","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/CMR.0000000000000157","article-title":"Defining the dermoscopic characteristics of fast-growing cutaneous melanomas","volume":"25","author":"Tejera-Vaquerizo","year":"2014","journal-title":"Melanoma Res."},{"key":"10.1016\/j.ad.2018.11.009_bib0680","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ad.2012.05.006","article-title":"Lentigo maligno","volume":"104","author":"Samaniego","year":"2013","journal-title":"Actas Dermosifiliogr."},{"key":"10.1016\/j.ad.2018.11.009_bib0685","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.jaad.2015.01.030","article-title":"Age, gender, and topography influence the clinical and dermoscopic appearance of lentigo maligna","volume":"72","author":"Tiodorovic-Zivkovic","year":"2015","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2018.11.009_bib0690","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2340\/00015555-2908","article-title":"Dysplastic vs. common naevus-associated vs. de novo melanomas: An observational retrospective study of 1,021 patients","volume":"98","author":"Martin-Gorgojo","year":"2018","journal-title":"Acta Derm Venereol."},{"key":"10.1016\/j.ad.2018.11.009_bib0695","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2147\/CLEP.S160357","article-title":"Influence of socioeconomic factors and region of residence on cancer stage of malignant melanoma: A Danish nationwide population-based study","volume":"10","author":"Ibfelt","year":"2018","journal-title":"Clin Epidemiol."},{"key":"10.1016\/j.ad.2018.11.009_bib0700","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1001\/jamadermatol.2018.0233","article-title":"Association of marital status with T stage at presentation and management of early-stage melanoma","volume":"154","author":"Sharon","year":"2018","journal-title":"JAMA Dermatology."},{"key":"10.1016\/j.ad.2018.11.009_bib0705","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1002\/cncr.26706","article-title":"Examining the pathways linking lower socioeconomic status and advanced melanoma","volume":"118","author":"Pollitt","year":"2012","journal-title":"Cancer."},{"key":"10.1016\/j.ad.2018.11.009_bib0710","first-page":"453","article-title":"Prevalence of whole-body skin self-examination in a population at high risk for skin cancer (Australia)","volume":"15","author":"Aitken","year":"2004","journal-title":"Cancer Causes Control."},{"key":"10.1016\/j.ad.2018.11.009_bib0715","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1002\/cncr.10855","article-title":"Strategies for improving melanoma education and screening for men age \u2265 50 years: Findings from the American Academy of Dermatology National Skin Cancer Screening Program","volume":"95","author":"Geller","year":"2002","journal-title":"Cancer."},{"key":"10.1016\/j.ad.2018.11.009_bib0720","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1002\/cncr.26707","article-title":"Behavioral determinants of successful early melanoma detection: Role of self and physician skin examination","volume":"118","author":"Swetter","year":"2012","journal-title":"Cancer."},{"key":"10.1016\/j.ad.2018.11.009_bib0725","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/1097-0215(20000520)89:3<271::AID-IJC10>3.0.CO;2-7","article-title":"Delays in diagnosis and melanoma prognosis (I): The role of patients","volume":"89","author":"Richard","year":"2000","journal-title":"Int J Cancer."},{"key":"10.1016\/j.ad.2018.11.009_bib0730","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/ajd.12437","article-title":"Scalp melanoma: Distinctive high risk clinical and histological features","volume":"58","author":"Xie","year":"2017","journal-title":"Australas J Dermatol."},{"key":"10.1016\/j.ad.2018.11.009_bib0735","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1002\/ijc.25540","article-title":"Association between melanoma thickness, clinical skin examination and socioeconomic status: Results of a large population-based study","volume":"128","author":"Youl","year":"2011","journal-title":"Int J Cancer."},{"issue":"1-2","key":"10.1016\/j.ad.2018.11.009_bib0740","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1127\/nova_hedwigia\/2016\/0350","article-title":"Radulotubus resupinatus gen. et sp. nov. with a poroid hymenophore in Pterulaceae (Agaricales Basidiomycota)","volume":"103","author":"Zhao","year":"2016","journal-title":"Nov Hedwigia."},{"key":"10.1016\/j.ad.2018.11.009_bib0745","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.suronc.2004.09.002","article-title":"Diagnosis of melanoma in the elderly and surgical implications","volume":"13","author":"Testori","year":"2004","journal-title":"Surg Oncol."},{"issue":"5 I","key":"10.1016\/j.ad.2018.11.009_bib0750","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0190-9622(97)80324-6","article-title":"Who removes pigmented skin lesions?","volume":"36","author":"Marks","year":"1997","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2018.11.009_bib0755","first-page":"S3","article-title":"A practical approach to selected problematic melanocytic lesions","volume":"121 Suppl","author":"Xu","year":"2004","journal-title":"Am J Clin Pathol."},{"key":"10.1016\/j.ad.2018.11.009_bib0760","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1001\/jamadermatol.2013.706","article-title":"Distinctive features of melanoma and its management in elderly patients: A population-based study in France","volume":"149","author":"Ciocan","year":"2013","journal-title":"JAMA Dermatology."},{"key":"10.1016\/j.ad.2018.11.009_bib0765","doi-asserted-by":"crossref","first-page":"538","DOI":"10.7150\/jca.2.538","article-title":"Malignant melanoma in the elderly: Different regional disease and poorer prognosis","volume":"2","author":"Macdonald","year":"2011","journal-title":"J Cancer."},{"key":"10.1016\/j.ad.2018.11.009_bib0770","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1001\/archotol.133.5.442","article-title":"Epidemiological features and prognostic factors of cutaneous head and neck melanoma: A population-based study","volume":"133","author":"Golger","year":"2007","journal-title":"Arch Otolaryngol - Head Neck Surg."},{"key":"10.1016\/j.ad.2018.11.009_bib0775","doi-asserted-by":"crossref","first-page":"6054","DOI":"10.1200\/JCO.2005.21.360","article-title":"Population-based assessment of surgical treatment trends for patients with melanoma in the era of sentinel lymph node biopsy","volume":"23","author":"Cormier","year":"2005","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.ad.2018.11.009_bib0780","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1001\/archderm.144.5.629","article-title":"Variations in management of stage i to stage iii cutaneous melanoma: A population-based study of clinical practices in France","volume":"144","author":"Grange","year":"2008","journal-title":"Arch Dermatol."},{"key":"10.1016\/j.ad.2018.11.009_bib0785","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1245\/s10434-015-4539-7","article-title":"Sentinel lymph node biopsy use among melanoma patients 75 years of age and older","volume":"22","author":"Sabel","year":"2015","journal-title":"Ann Surg Oncol."},{"key":"10.1016\/j.ad.2018.11.009_bib0790","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1200\/JCO.2008.18.7567","article-title":"Health care system and socioeconomic factors associated with variance in use of sentinel lymph node biopsy for melanoma in the United States","volume":"27","author":"Lange","year":"2009","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.ad.2018.11.009_bib0795","doi-asserted-by":"crossref","first-page":"e247","DOI":"10.1111\/jdv.14019","article-title":"Making decisions on sentinel lymph node biopsy for malignant melanoma: Prioritization of determinants using a decision tree","volume":"31","author":"Moreno-Ram\u00edrez","year":"2017","journal-title":"J Eur Acad Dermatology Venereol."},{"key":"10.1016\/j.ad.2018.11.009_bib0800","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/CMR.0b013e328329fe95","article-title":"Cutaneous melanoma in the elderly","volume":"19","author":"Testori","year":"2009","journal-title":"Melanoma Res."},{"key":"10.1016\/j.ad.2018.11.009_bib0805","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/01.sla.0000181092.50141.fa","article-title":"Sentinel node biopsy for early-stage melanoma: Accuracy and morbidity in MSLT-I, an international multicenter trial","volume":"242","author":"Morton","year":"2005","journal-title":"Ann Surg."},{"key":"10.1016\/j.ad.2018.11.009_bib0810","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/bjs.7565","article-title":"Sentinel lymph node biopsy and survival in elderly patients with cutaneous melanoma","volume":"98","author":"Koskivuo","year":"2011","journal-title":"Br J Surg."},{"key":"10.1016\/j.ad.2018.11.009_bib0815","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jss.2013.05.090","article-title":"Age-related disparities in use of completion lymphadenectomy for melanoma sentinel lymph node met\u00e1stasis","volume":"185","author":"Shah","year":"2013","journal-title":"J Surg Res."},{"key":"10.1016\/j.ad.2018.11.009_bib0820","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1245\/s10434-008-9885-2","article-title":"Complete lymph node dissection for sentinel node-positive melanoma: Assessment of practice patterns in the United States","volume":"15","author":"Bilimoria","year":"2008","journal-title":"Ann Surg Oncol."},{"key":"10.1016\/j.ad.2018.11.009_bib0825","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMoa1613210","article-title":"Completion dissection or observation for sentinel-node metastasis in melanoma","volume":"376","author":"Faries","year":"2017","journal-title":"N Engl J Med."},{"key":"10.1016\/j.ad.2018.11.009_bib0830","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejca.2018.04.014","article-title":"The effect of age on outcomes after isolated limb perfusion for advanced extremity malignancies","volume":"100","author":"Smith","year":"2018","journal-title":"Eur J Cancer."},{"key":"10.1016\/j.ad.2018.11.009_bib0835","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1245\/s10434-017-6046-5","article-title":"Safety and efficacy of isolated limb infusion chemotherapy for advanced locoregional melanoma in elderly patients: An australian multicenter study","volume":"24","author":"Kroon","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ad.2018.11.009_bib0840","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1007\/BF02574514","article-title":"Safety and efficacy of isolated limb perfusion in elderly melanoma patients","volume":"9","author":"Noorda","year":"2002","journal-title":"Ann Surg Oncol."},{"key":"10.1016\/j.ad.2018.11.009_bib0845","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1245\/s10434-017-5803-9","article-title":"Isolated limb perfusion for melanoma is safe and effective in elderly patients","volume":"24","author":"Madu","year":"2017","journal-title":"Ann Surg Oncol."},{"key":"10.1016\/j.ad.2018.11.009_bib0850","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11912-018-0656-3","article-title":"Melanoma immunotherapy in the elderly","volume":"20","author":"Orloff","year":"2018","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.ad.2018.11.009_bib0855","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1200\/JCO.2013.54.8347","article-title":"International society of geriatric oncology consensus on geriatric assessment in older patients with cancer","volume":"32","author":"Wildiers","year":"2014","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.ad.2018.11.009_bib0860","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/sj.jid.5700632","article-title":"Distinct clinical and pathological features are associated with the BRAFT1799A(V600E) mutation in primary melanoma","volume":"127","author":"Liu","year":"2007","journal-title":"J Invest Dermatol."},{"key":"10.1016\/j.ad.2018.11.009_bib0865","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1158\/1078-0432.CCR-12-0052","article-title":"Distinguishing clinicopathologic features of patients with V600E and V600K BRAF-mutant metastatic melanoma","volume":"18","author":"Menzies","year":"2012","journal-title":"Clin Cancer Res."},{"key":"10.1016\/j.ad.2018.11.009_bib0870","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1200\/JCO.2012.41.6727","article-title":"Under-representation of older adults in cancer registration trials: Known problem, little progress","volume":"30","author":"Scher","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ad.2018.11.009_bib0875","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1056\/NEJMoa1412690","article-title":"Improved overall survival in melanoma with combined dabrafenib and trametinib","volume":"372","author":"Robert","year":"2015","journal-title":"N Engl J Med."},{"key":"10.1016\/j.ad.2018.11.009_bib0880","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1056\/NEJMoa1408868","article-title":"Combined vemurafenib and cobimetinib in BRAF-mutated melanoma","volume":"371","author":"Larkin","year":"2014","journal-title":"N Engl J Med."},{"key":"10.1016\/j.ad.2018.11.009_bib0885","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S1470-2045(14)70051-8","article-title":"Vemurafenib in patients with BRAFV600mutated metastatic melanoma: An open-label, multicentre, safety study","volume":"15","author":"Larkin","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ad.2018.11.009_bib0890","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1056\/NEJMoa1104621","article-title":"Ipilimumab plus dacarbazine for previously untreated metastatic melanoma","volume":"364","author":"Robert","year":"2011","journal-title":"N Engl J Med."},{"key":"10.1016\/j.ad.2018.11.009_bib0895","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1056\/NEJMoa1412082","article-title":"Nivolumab in previously untreated melanoma without BRAF mutation","volume":"372","author":"Robert","year":"2015","journal-title":"N Engl J Med."},{"key":"10.1016\/j.ad.2018.11.009_bib0900","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1056\/NEJMoa1414428","article-title":"Nivolumab and ipilimumab versus ipilimumab in untreated melanoma","volume":"372","author":"Postow","year":"2015","journal-title":"N Engl J Med."},{"key":"10.1016\/j.ad.2018.11.009_bib0905","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1634\/theoncologist.2016-0450","article-title":"Impact of age on outcomes with immunotherapy for patients with melanoma","volume":"22","author":"Betof","year":"2017","journal-title":"Oncologist."},{"key":"10.1016\/j.ad.2018.11.009_bib0910","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1001\/jamadermatol.2017.4584","article-title":"Association of immunotherapy with overall survival in elderly patients with melanoma","volume":"154","author":"Perier-Muzet","year":"2018","journal-title":"JAMA Dermatology."},{"key":"10.1016\/j.ad.2018.11.009_bib0915","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1158\/1078-0432.CCR-18-1116","article-title":"Age correlates with response to anti-PD1 reflecting age-related differences in intratumoral effector and regulatory T-cell populations","volume":"24","author":"Kugel","year":"2018","journal-title":"Clin Cancer Res."},{"key":"10.1016\/j.ad.2018.11.009_bib0920","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.exger.2017.10.002","article-title":"Considerations for successful cancer immunotherapy in aged hosts","volume":"107","author":"Hurez","year":"2018","journal-title":"Exp Gerontol."},{"key":"10.1016\/j.ad.2018.11.009_bib0925","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000351499","article-title":"Impact of age on the management of primary melanoma patients","volume":"85","author":"Fleming","year":"2013","journal-title":"Oncol."},{"key":"10.1016\/j.ad.2018.11.009_bib0930","doi-asserted-by":"crossref","unstructured":"Bastiaannet E, Battisti N, Loh KP, de Glas N, Soto-Perez-de-Celis E, Baldini C et al. Immunotherapy and targeted therapies in older patients with advanced melanoma. Young International Society of Geriatric Oncology review paper. J Geriatr Oncol. 2018 (Epub ahead of print)","DOI":"10.1016\/j.jgo.2018.06.009"}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731019301231?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731019301231?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T01:09:30Z","timestamp":1757552970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731019301231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":93,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0001731019301231"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2018.11.009","relation":{},"ISSN":["0001-7310"],"issn-type":[{"value":"0001-7310","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Melanoma cut\u00e1neo en el anciano: revisi\u00f3n de un problema creciente","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2018.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 AEDV. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}